Published on 27 Jan 2023 on Zacks via Yahoo Finance
Dr. Reddy's (RDY) Q3 Earnings & Revenues Beat Estimates
Dr. Reddy's Laboratories Limited RDY reported third-quarter fiscal 2023 earnings of 91 cents per American Depositary Share, which beat the Zacks Consensus Estimate and our estimate of earnings of 60 cents. In the year-ago quarter, the company reported earnings of 51 cents.
In third-quarter fiscal 2023, revenues grew 27.2% year over year to $818 million, surpassing the Zacks Consensus Estimate of $769 million. Total revenues were higher than our estimate of $761.2 million in the reported quarter.
Shares of the company have decreased 4.4% in the past year compared with the industry’s decline of 12.1%.